Supported by

TAVI (Transcatheter aortic valve implantation)

Latest TAVI content in interventional cardiology - research, practice, and education

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1469 results

TAVI procedural complications - Part 1: VSD, valve embolisation, and more

19 May 2026 – From EuroPCR 2026

This session focuses on the complex complications that can arise during TAVI procedures, such as ventricular septal defects, valve embolisation, and other critical events. Through detailed case analyses, it offers strategies for recognition, prevention, and management to improve patient safety and outcomes.

TAVI procedural complications - Part 2: devices issues, access-related complications and more

19 May 2026 – From EuroPCR 2026

Delve into procedural challenges encountered during TAVI, focusing on device-related issues, access complications, and bailout strategies. This session reviews real-world cases such as balloon retention, valve expansion failure, TAV-in-TAV interventions, and transcaval access lessons, providing critical insights to manage and mitigate procedural complications effectively.

Re-intervention challenges after first aortic valve replacement

19 May 2026 – From EuroPCR 2026

Addressing the challenges of re-intervention after initial aortic valve replacement, this session highlights advanced valve-in-valve TAVI strategies, including leaflet modification techniques, management of extreme coronary obstruction risks, and complex anatomical considerations such as post-Bentall root anatomy.

Identifying problems and solving complex anatomies during TAVI

19 May 2026 – From EuroPCR 2026

A comprehensive session on managing complex anatomies during Transcatheter Aortic Valve Implantation (TAVI), emphasizing risk markers for peri-operative complications and strategies to address difficult anatomical challenges. Real-world cases illustrate practical approaches and key learnings for handling intricate TAVI scenarios.

Managing difficult TAVI scenarios

19 May 2026 – From EuroPCR 2026

Focused on complex TAVI cases, this session reviews guideline recommendations for TAVI in younger patients, strategies for managing concomitant coronary artery disease, and considerations for treating asymptomatic severe aortic stenosis. Real-world cases illustrate clinical decision-making and outcomes.

TAVI: Opening LIVE Educational Case from Clinique Pasteur - Toulouse, France

19 May 2026 – From EuroPCR 2026

This live educational case from Clinique Pasteur in Toulouse, France, focuses on optimal management of coronary artery disease (CAD) in patients undergoing TAVI. The session reviews patient imaging, operator strategies, procedural execution, and key learnings from complex CAD scenarios impacting TAVI outcomes.

TAVI for degenerated surgical aortic bioprotheses: procedural challenges

19 May 2026 – From EuroPCR 2026

This session addresses the procedural challenges inherent in transcatheter aortic valve implantation (TAVI) for degenerated surgical aortic bioprostheses. It covers high-risk valve-in-valve implantation cases as last-resort therapies, management of drifting bioprostheses, and interventions in failed small non-fracturable valves threatening coronary arteries. Techniques such as BASILICA and...

Clinical cases - Nurses and Allied Professionals

19 May 2026 – From EuroPCR 2026

Dedicated to nurses and allied health professionals, this session presents compelling clinical cases illustrating their critical role in interventional cardiology. Topics range from managing pregnant patients in the cath lab, the impactful contributions of nursing and allied professionals (NAPs), to their management perspectives during complex procedures...

TAVI complications and management strategies

19 May 2026 – From EuroPCR 2026

Gain comprehensive knowledge on anticipating, identifying, and managing complications during transcatheter aortic valve implantation (TAVI). Through complex international case studies—including transaxillary Navitor implantation and bicuspid aortic valve challenges—this session highlights key strategies to improve procedural safety and outcomes.

PCR's Got Talent Round 1 - Session 1

19 May 2026 – From EuroPCR 2026

This dynamic session from PCR's Got Talent Round 1 presents a diverse array of cutting-edge research and clinical findings. Topics include the influence of local and systemic inflammation on PCI outcomes, adherence to OCT-guided PCI metrics, comparative guidance strategies using angiography-derived FFR and IVUS, and the...

Managing life-threatening TAVI complications

19 May 2026 – From EuroPCR 2026

Manage life-threatening complications in TAVI procedures with a structured algorithm for identification and resolution. This session shares expert tips for handling specific severe complications and reviews best practices aimed at complication avoidance to enhance patient safety and procedural success.

Structural and valvular innovations

19 May 2026 – From EuroPCR 2026

This session highlights the latest innovations in structural and valvular cardiology, featuring novel technologies such as a new self-expandable transcatheter aortic valve for aortic stenosis treatment and a temporary atrioventricular sequential pacing system. It also discusses non-clinical testing methodologies supporting U.S. market approvals, non-invasive ultrasound therapy...

Disrupting the aorta and valves: the next transcatheter wave

18 May 2026 – From EuroPCR 2026

Delve into the next wave of transcatheter interventions disrupting the aorta and valves. This session covers pioneering minimally invasive ascending aortic repair, novel polymeric aortic valve implants, and innovative devices for tricuspid repair and leaflet replacement.

Rapid fire session on next generation structural heart and valve therapies

18 May 2026 – From EuroPCR 2026

An intensive rapid-fire session presenting the latest advancements in next-generation structural heart and valve therapies, including novel transcatheter systems for aortic and mitral valve repair, innovative solutions for tricuspid regurgitation, and implant-free PFO closure technologies.

How to plan and perform TAVI in more challenging tricuspid AS anatomies?

12 May 2026

Watch this replay to learn how to anticipate anatomical challenges and optimize TAVI planning in complex tricuspid AS cases.

How to plan and perform TAVI in more challenging tricuspid AS anatomies?

High calcium, high stakes: managing severe AS with complex multivessel disease

12 May 2026

A 69-year-old woman with severe symptomatic aortic stenosis (NYHA III) and complex comorbidities, including three-vessel coronary artery disease, advanced COPD, and peripheral artery disease, presents with progressive dyspnoea despite recent PCI. How would you treat this patient?

Author

Matti Adam

Author

Ole De Backer
Won-Keun Kim

Author

Won-Keun Kim
High calcium, high stakes: managing severe AS with complex multivessel disease

Getting it right the first time: Optimising the index TAVI for durable outcomes in young and intermediate / Low-risk patients

28 Apr 2026

Join A. Öner, D. Buckert and A. Khokhar as they explore multidisciplinary decision-making, lifetime management in low and intermediate-risk TAVI patients.

Getting it right the first time: Optimising the index TAVI for durable outcomes in young and intermediate / Low-risk patients

Aortic stenosis and coronary artery disease: which should be treated first?

28 Apr 2026

In this review, Henryk Dreger explores the complex interplay between aortic stenosis and coronary artery disease, highlighting the latest evidence on PCI timing and its implications for clinical decision-making.

Henryk Dreger

Author

Henryk Dreger
Aortic stenosis and coronary artery disease: which should be treated first?

Self-made steerable catheter to cross the aortic valve in severe aortic stenosis

15 Apr 2026

When standard catheters and wires repeatedly fail to cross a severely stenotic aortic valve, a simple modification of readily available equipment may provide a solution.

This step-by-step tutorial explains how to create and use a self-made steerable catheter system to facilitate valve crossing in complex TAVI anatomies.

Author

Osama Bisht
Won-Keun Kim

Author

Won-Keun Kim
Robert R. Flieger

Author

Robert R. Flieger
Self-made steerable catheter to cross the aortic valve in severe aortic stenosis

Rapid CT-guided emergency TAVI-in-TAVI-in-valve for cardiogenic shock with high coronary obstruction risk

14 Apr 2026

An 85-year-old man presented in cardiogenic shock with torrential aortic regurgitation after prior surgical and TAVI valve-in-valve procedures. With high coronary obstruction risk, urgent CT assessment and in-silico simulations guided a rapid redo TAVI-in-TAVI-in-valve implantation, demonstrating that CT-assisted emergency redo-TAVI is feasible and lifesaving in high-risk...

Rapid CT-guided emergency TAVI-in-TAVI-in-valve for cardiogenic shock with high coronary obstruction risk